burnin1
Well-Known Member
From NORML
Gallup: One in Seven Americans Use CBD Products
Thursday, 22 August 2019
Princeton, NJ: An estimated one in seven US adults acknowledges using CBD-infused products, according to national polling data compiled by Gallup.
Fourteen percent of Americans say that they utilize CBD. Use is most prevalent among those between the ages of 18 to 29.
Those consuming CBD products were most likely to report using them for pain (40 percent), anxiety (20 percent), or insomnia (11 percent).
In December, Congress enacted legislation removing industrial hemp (defined as cannabis containing less than 0.3 percent THC) and products containing cannabinoids derived from hemp from the federal Controlled Substances Act. However, regulators at the US Food and Drug Administration have taken the position that such products cannot legally be marketed as either medicines, food additives, or health supplements. The agency has established a working group to address the issue, but has cautioned that regulations may not be forthcoming for some time.
For more information, see the NORML fact-sheet 'FAQs About Cannabidiol.'
https://norml.org/news/2019/08/22/g...&email_subject=norml-news-of-the-week-8222019
Gallup: One in Seven Americans Use CBD Products
Thursday, 22 August 2019
Princeton, NJ: An estimated one in seven US adults acknowledges using CBD-infused products, according to national polling data compiled by Gallup.
Fourteen percent of Americans say that they utilize CBD. Use is most prevalent among those between the ages of 18 to 29.
Those consuming CBD products were most likely to report using them for pain (40 percent), anxiety (20 percent), or insomnia (11 percent).
In December, Congress enacted legislation removing industrial hemp (defined as cannabis containing less than 0.3 percent THC) and products containing cannabinoids derived from hemp from the federal Controlled Substances Act. However, regulators at the US Food and Drug Administration have taken the position that such products cannot legally be marketed as either medicines, food additives, or health supplements. The agency has established a working group to address the issue, but has cautioned that regulations may not be forthcoming for some time.
For more information, see the NORML fact-sheet 'FAQs About Cannabidiol.'
https://norml.org/news/2019/08/22/g...&email_subject=norml-news-of-the-week-8222019
